Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

Alkermes (Group)

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases and oncology. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for diseases that include schizophrenia, depression, addiction, multiple sclerosis, and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. *

 

Period Start 1997-06-28 existent
Product Industry pharmaceutical
     
Region Region Cambridge, MA
  Country United States (USA)
  Street 1 Burlington Road
Connaught House
  City D04 C5Y6 Dublin
  Tel +353-1-772-8000
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
  Currency USD
  Annual sales 240,717,000 (revenue, total, consolidated (07/08) 2008-03-31)
  Profit 166,979,000 (2008-03-31)
  Cash 460,361,000 (2008-03-31)
     
    * Document for �About Section�: Rodin Therapeutics Inc.. (11/18/19). "Press Release: Alkermes to Acquire Rodin Therapeutics". Dublin & Boston, MA.
     
   
Record changed: 2019-11-30

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Alkermes (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture [iito] Back into Ad 650x80px




» top